SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-154640
Filing Date
2016-11-03
Accepted
2016-11-03 17:19:51
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17223_110q.htm 10-Q 963755
2 EX-10.71 a16-17223_1ex10d71.htm EX-10.71 868533
3 EX-31.1 a16-17223_1ex31d1.htm EX-31.1 9749
4 EX-31.2 a16-17223_1ex31d2.htm EX-31.2 10245
5 EX-32 a16-17223_1ex32.htm EX-32 9788
  Complete submission text file 0001104659-16-154640.txt   5782109

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inva-20160930.xml EX-101.INS 1155687
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20160930.xsd EX-101.SCH 43283
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20160930_cal.xml EX-101.CAL 57960
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20160930_def.xml EX-101.DEF 137696
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20160930_lab.xml EX-101.LAB 387647
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20160930_pre.xml EX-101.PRE 260314
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 161972799
SIC: 2834 Pharmaceutical Preparations